Acasti Pharma Company Profile (NASDAQ:ACST)

About Acasti Pharma (NASDAQ:ACST)

Acasti Pharma logoAcasti Pharma Inc is a Canada-based biopharmaceutical company. The Company is focused on the research, development and commercialization of prescription drugs using omega 3 fatty acids (OM3s) derived from krill oil. OM3s has clinical evidence of safety and efficacy in lowering triglycerides in patients with hypertriglyceridemia (HTG). The Company's drug candidate is CaPre, an OM3 phospholipid, which is being developed for the treatment of severe hypertriglyceridemia, a condition characterized by abnormally high levels of triglycerides in the bloodstream (over 500 mg/dL) (severe hypertriglyceridemia or severe HTG).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Pharmaceuticals - NEC
  • Sub-Industry: N/A
  • Symbol: NASDAQ:ACST
  • CUSIP: N/A
  • Web: www.acastipharma.com
Capitalization:
  • Market Cap: $18.83 million
  • Outstanding Shares: 14,712,000
Average Prices:
  • 50 Day Moving Avg: $1.30
  • 200 Day Moving Avg: $1.29
  • 52 Week Range: $1.11 - $3.09
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.0000
Sales & Book Value:
  • Annual Revenue: N/A
  • Price / Sales: N/A
  • Book Value: $1.17 per share
  • Price / Book: 1.18
Profitability:
  • EBIDTA: ($6,190,000.00)
  • Net Margins: -35,290.48%
  • Return on Equity: -47.38%
  • Return on Assets: -43.03%
Debt:
  • Debt-to-Equity Ratio: 0.06%
  • Current Ratio: 4.55%
  • Quick Ratio: 4.55%
Misc:
  • Average Volume: 23,976 shs.
  • Beta: 1.22
  • Short Ratio: 4.2
 
Frequently Asked Questions for Acasti Pharma (NASDAQ:ACST)

What is Acasti Pharma's stock symbol?

Acasti Pharma trades on the NASDAQ under the ticker symbol "ACST."

How were Acasti Pharma's earnings last quarter?

Acasti Pharma, Inc. (NASDAQ:ACST) posted its earnings results on Tuesday, January, 15th. The company reported ($0.02) EPS for the quarter. Acasti Pharma had a negative return on equity of 47.38% and a negative net margin of 35,290.48%. View Acasti Pharma's Earnings History.

Who are some of Acasti Pharma's key competitors?

Who are Acasti Pharma's key executives?

Acasti Pharma's management team includes the folowing people:

  • Roderick Noel Carter, Executive Chairman of the Board
  • Janelle D'Alvise, President, Chief Executive Officer
  • Linda O'Keefe, Chief Financial Officer
  • Pierre Lemieux Ph.D., Chief Operating Officer
  • Laurent Harvey, Vice President- Clinical and Non-Clinical Affairs
  • Jean-Daniel Belanger, Secretary, Director- Corporate Affairs
  • Valier Boivin, Independent Director
  • Jean-Claude Debard, Independent Director
  • Ronald Denis, Independent Director
  • Pierre Fitzgibbon, Independent Director

How do I buy Acasti Pharma stock?

Shares of Acasti Pharma can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Acasti Pharma's stock price today?

One share of Acasti Pharma stock can currently be purchased for approximately $1.38.


MarketBeat Community Rating for Acasti Pharma (NASDAQ ACST)
Community Ranking:  3.3 out of 5 (  )
Outperform Votes:  8 (Vote Outperform)
Underperform Votes:  4 (Vote Underperform)
Total Votes:  12
MarketBeat's community ratings are surveys of what our community members think about Acasti Pharma and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Acasti Pharma (NASDAQ:ACST) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Acasti Pharma (NASDAQ:ACST)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Acasti Pharma (NASDAQ:ACST)
Earnings by Quarter for Acasti Pharma (NASDAQ:ACST)
Earnings History by Quarter for Acasti Pharma (NASDAQ ACST)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/15/2013Q313($0.02)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Acasti Pharma (NASDAQ:ACST)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Acasti Pharma (NASDAQ:ACST)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Acasti Pharma (NASDAQ:ACST)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Acasti Pharma (NASDAQ:ACST)
Latest Headlines for Acasti Pharma (NASDAQ:ACST)
Source:
DateHeadline
finance.yahoo.com logoAcasti Pharma Grants Stock Options
finance.yahoo.com - June 14 at 3:17 PM
finance.yahoo.com logoAcasti Pharma To Present at Upcoming International Industry Conferences
finance.yahoo.com - June 12 at 3:43 PM
finance.yahoo.com logoAcasti Pharma and CordenPharma Announce Large Scale Production of CaPre® with New Continuous Manufacturing Process
finance.yahoo.com - May 31 at 11:15 AM
americanbankingnews.com logoAcasti Pharma (ACST) Given Daily News Sentiment Score of 0.12
www.americanbankingnews.com - April 30 at 11:17 AM
streetinsider.com logoAcasti Pharma (ACST) Announces Additional Composition & Use Patents in Taiwan and Australia
www.streetinsider.com - April 24 at 11:12 AM
finance.yahoo.com logoAcasti Granted Additional Composition & Use Patents in Taiwan and Australia; Safeguards Valuable Market Expansion Opportunities
finance.yahoo.com - April 24 at 11:12 AM
americanbankingnews.com logoAcasti Pharma (ACST) Given Media Sentiment Rating of 0.35
www.americanbankingnews.com - April 20 at 7:35 AM
americanbankingnews.com logoAcasti Pharma (ACST) Earns Daily Media Impact Rating of 0.10
www.americanbankingnews.com - April 15 at 8:44 AM
us.rd.yahoo.com logoAcasti Pharma Provides Update On CaPre Phase 3 Development Program
us.rd.yahoo.com - March 30 at 3:32 PM
finance.yahoo.com logoAcasti Pharma Grants Incentive Stock and Options
finance.yahoo.com - February 24 at 3:17 PM
streetinsider.com logoAcasti Pharma (ACST) Reports Proposed Private Placement of Conv. Debentures, Amended Offering of Units
www.streetinsider.com - February 2 at 8:21 PM
us.rd.yahoo.com logoAcasti Pharma Announces Proposed Private Placement of Convertible Debentures and Amended Proposed Offering of Units
us.rd.yahoo.com - February 2 at 3:18 PM
finance.yahoo.com logoBiotech Industry a Focus in 2017: Latest Reports on Nektar Therapeutics and Acasti Pharma
finance.yahoo.com - January 25 at 3:23 PM
rttnews.com logoAcasti Pharma Inc. (ACST) Is Spiking Higher In Early Trade
www.rttnews.com - December 23 at 8:25 PM
us.rd.yahoo.com logo8:01 am Acasti Pharma announces that Linda O'Keefe has been named CFO
us.rd.yahoo.com - November 30 at 10:22 AM
streetinsider.com logoAcasti Pharma (ACST) Names New CFO
www.streetinsider.com - November 29 at 3:46 PM
247wallst.com logoAcasti Pharma Share Gains Massive in Percentage Terms, Tiny in Dollars
247wallst.com - September 14 at 8:34 PM
finance.yahoo.com logoAcasti Pharma Reports Positive CaPre Omega-3 Bridging Study Data
finance.yahoo.com - September 14 at 9:49 AM
finance.yahoo.com logoAcasti Announces Grant of Stock Options
finance.yahoo.com - May 30 at 8:00 AM
finance.yahoo.com logoJan D'Alvise Appointed President & CEO of Acasti Pharma
finance.yahoo.com - May 12 at 8:08 AM
finance.yahoo.com logoAcasti Pharma Inc. (ACST)
finance.yahoo.com - January 27 at 11:09 AM
finance.yahoo.com logo5:10 pm Acasti Pharma reports Q3 net loss of ($2.191 mln) vs $3.012 mln last year
finance.yahoo.com - January 12 at 5:10 PM
finance.yahoo.com logoACASTI PHARMA INC. Financials
finance.yahoo.com - December 8 at 1:12 PM
finance.yahoo.com logoAcasti Announces Second Quarter Results
finance.yahoo.com - October 14 at 5:10 PM
finance.yahoo.com logoAcasti Pharma Gains Ahead Of Expected Phase II Results
finance.yahoo.com - February 26 at 2:24 PM

Social

Chart

Acasti Pharma (ACST) Chart for Thursday, July, 27, 2017

This page was last updated on 7/27/2017 by MarketBeat.com Staff